Movement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Strong Q4 Guidance and AI Drug Discovery Demand Continue to Lift Shares

Market Focus08-18

On August 18, Twist Bioscience Corp rose 5.07% in regular trading, trading at $124.45/share, with turnover of $99.76 million. The stock rebounded following a prior session pullback, driven by continued positive sentiment from its fiscal Q3 earnings report released on August 3.

The company reported Q3 revenue of $118.4 million, beating the consensus estimate of $114.5 million, marking its 14th consecutive quarter of growth with 23% year-over-year expansion. More notably, management issued Q4 revenue guidance of $123 million to $124 million, significantly exceeding the FactSet estimate of $117.4 million. The CEO indicated the company expects to reach adjusted EBITDA breakeven this quarter.

As a core DNA synthesis supplier in the AI drug discovery value chain, Twist Bioscience is deeply tied to growing demand from AI-driven protein engineering and drug candidate screening. The company recently completed a $300 million equity offering underwritten by top-tier investment banks to expand production capacity. Analysts maintain a consensus buy rating with a mean price target of $87.56, while the stock has gained approximately 295% year-to-date.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157820547?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 03:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157820547","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Strong Q4 Guidance and AI Drug Discovery Demand Continue to Lift Shares","media":"Market Focus","content":"<p><p>On August 18, Twist Bioscience Corp rose 5.07% in regular trading, trading at $124.45/share, with turnover of $99.76 million. The stock rebounded following a prior session pullback, driven by continued positive sentiment from its fiscal Q3 earnings report released on August 3.</p><p>The company reported Q3 revenue of $118.4 million, beating the consensus estimate of $114.5 million, marking its 14th consecutive quarter of growth with 23% year-over-year expansion. More notably, management issued Q4 revenue guidance of $123 million to $124 million, significantly exceeding the FactSet estimate of $117.4 million. The CEO indicated the company expects to reach adjusted EBITDA breakeven this quarter.</p><p>As a core DNA synthesis supplier in the AI drug discovery value chain, Twist Bioscience is deeply tied to growing demand from AI-driven protein engineering and drug candidate screening. The company recently completed a $300 million equity offering underwritten by top-tier investment banks to expand production capacity. Analysts maintain a consensus buy rating with a mean price target of $87.56, while the stock has gained approximately 295% year-to-date.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Strong Q4 Guidance and AI Drug Discovery Demand Continue to Lift Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Strong Q4 Guidance and AI Drug Discovery Demand Continue to Lift Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-18 03:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 18, Twist Bioscience Corp rose 5.07% in regular trading, trading at $124.45/share, with turnover of $99.76 million. The stock rebounded following a prior session pullback, driven by continued positive sentiment from its fiscal Q3 earnings report released on August 3.</p><p>The company reported Q3 revenue of $118.4 million, beating the consensus estimate of $114.5 million, marking its 14th consecutive quarter of growth with 23% year-over-year expansion. More notably, management issued Q4 revenue guidance of $123 million to $124 million, significantly exceeding the FactSet estimate of $117.4 million. The CEO indicated the company expects to reach adjusted EBITDA breakeven this quarter.</p><p>As a core DNA synthesis supplier in the AI drug discovery value chain, Twist Bioscience is deeply tied to growing demand from AI-driven protein engineering and drug candidate screening. The company recently completed a $300 million equity offering underwritten by top-tier investment banks to expand production capacity. Analysts maintain a consensus buy rating with a mean price target of $87.56, while the stock has gained approximately 295% year-to-date.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1157820547","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157820547","pubTimestamp":1786996796,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 18, Twist Bioscience Corp rose 5.07% in regular trading, trading at $124.45/share, with turnover of $99.76 million. The stock rebounded following a prior session pullback, driven by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势提醒|Twist Bioscience Corp 常规交易中上涨 5.07%，强劲的第四季度指引和人工智能药物发现需求继续提振股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 18, Twist Bioscience Corp rose 5.07% in regular trading, trading at $124.45/share, with turnover of $99.76 million. The stock rebounded following a prior session pullback, driven by continued positive sentiment from its fiscal Q3 earnings report released on August 3.The company reported Q3 revenue of $118.4 million, beating the consensus estimate of $114.5 million, marking its 14th consecutive quarter of growth with 23% year-over-year expansion. More notably, management issued Q4 revenue guidance of $123 million to $124 million, significantly exceeding the FactSet estimate of $117.4 million. The CEO indicated the company expects to reach adjusted EBITDA breakeven this quarter.As a core DNA synthesis supplier in the AI drug discovery value chain, Twist Bioscience is deeply tied to growing demand from AI-driven protein engineering and drug candidate screening. The company recently completed a $300 million equity offering underwritten by top-tier investment banks to expand production capacity. Analysts maintain a consensus buy rating with a mean price target of $87.56, while the stock has gained approximately 295% year-to-date.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157820547","isCrawlerRequest":true}